Skip to Main Content
Table 4

Overall survival in node-negative NSCLC according to integrin α5 gene expression

α5 status (n)5-yr survival rate (%)P
OverexpressionNormal expressionOverexpressionNormal expression
Age      
≦60 7 17 69.7 85.7 0.330 
>60 27 37 59.3 81.1 0.018 
Gender      
Female 10 15 70.0 73.3 0.482 
Male 34 29 61.3 86.2 0.017 
Tumor size      
≦3 cm 16 15 81.2 86.7 0.642 
>3 cm 28 29 52.8 79.3 0.014 
Histology      
AD 25 28 60.0 78.6 0.092 
SQ 16 14 68.8 85.7 0.176 
LA 3 2 66.7 100 0.456 
Differentiation      
Well 6 16 66.7 87.5 0.263 
Moderately 24 20 66.2 70.0 0.596 
Poorly 14 8 57.1 100.0 0.026 
Total patients 44 44 63.2 81.8 0.016 
α5 status (n)5-yr survival rate (%)P
OverexpressionNormal expressionOverexpressionNormal expression
Age      
≦60 7 17 69.7 85.7 0.330 
>60 27 37 59.3 81.1 0.018 
Gender      
Female 10 15 70.0 73.3 0.482 
Male 34 29 61.3 86.2 0.017 
Tumor size      
≦3 cm 16 15 81.2 86.7 0.642 
>3 cm 28 29 52.8 79.3 0.014 
Histology      
AD 25 28 60.0 78.6 0.092 
SQ 16 14 68.8 85.7 0.176 
LA 3 2 66.7 100 0.456 
Differentiation      
Well 6 16 66.7 87.5 0.263 
Moderately 24 20 66.2 70.0 0.596 
Poorly 14 8 57.1 100.0 0.026 
Total patients 44 44 63.2 81.8 0.016 
View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept